Dr. Julia Foldi, MD, PhD
Claim this profileUniversity of Pittsburgh Cancer Institute (UPCI)
Studies Breast Cancer
Studies Breast cancer
8 reported clinical trials
17 drugs studied
Area of expertise
1Breast Cancer
Stage IV
HER2 negative
ER positive
2Breast Cancer
Stage IV
HER2 negative
ER positive
Affiliated Hospitals
Clinical Trials Julia Foldi, MD, PhD is currently running
Symptom Monitoring
for Young Women on Hormone Therapy
This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
More about Julia Foldi, MD, PhD
Clinical Trial Related2 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Julia Foldi, MD, PhD has experience with
- Paclitaxel
- Pembrolizumab
- Durvalumab
- Binimetinib
- Fulvestrant
- Copanlisib Hydrochloride
Breakdown of trials Julia Foldi, MD, PhD has run
Breast Cancer
Breast cancer
Skin Cancer
Chest Wall Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Julia Foldi, MD, PhD specialize in?
Julia Foldi, MD, PhD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Julia Foldi, MD, PhD currently recruiting for clinical trials?
Yes, Julia Foldi, MD, PhD is currently recruiting for 5 clinical trials in Pittsburgh Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Julia Foldi, MD, PhD has studied deeply?
Yes, Julia Foldi, MD, PhD has studied treatments such as Paclitaxel, Pembrolizumab, Durvalumab.
What is the best way to schedule an appointment with Julia Foldi, MD, PhD?
Apply for one of the trials that Julia Foldi, MD, PhD is conducting.
What is the office address of Julia Foldi, MD, PhD?
The office of Julia Foldi, MD, PhD is located at: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania 15232 United States. This is the address for their practice at the University of Pittsburgh Cancer Institute (UPCI).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.